Longboard Pharmaceuticals (LBPH)
(Real Time Quote from BATS)
$35.20 USD
+0.11 (0.31%)
Updated Aug 12, 2024 09:54 AM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Brokerage Reports
Longboard Pharmaceuticals, Inc. [LBPH]
Reports for Purchase
Showing records 21 - 40 ( 65 total )
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
PACIFIC Delivers For LBPH and Bexicaserin (LP352); Top-Line Results, Takeaways
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
What Will 2024 Bring? LP352 PACIFIC Data To Start; Thoughts Into The Readout
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
KOL Call Invite: Epilepsy KOL Check - AES Wrap and Thoughts Into 2024
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for LBPH 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
3Q23 Results; Top-line Phase 2 Data with Lead GPCR Program in Epilepsy Expected January 2024; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Waiting on PACIFIC, An Uneventful 3Q23 Update For Now
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Investor Event Highlights Potential Blockbuster LP352 Differentiation in Epilepsy; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
LP352 Time To Shine Approaches With PACIFIC Readout Tracking to January
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Key Takeaways From 25th Annual Global Conference: Multiple Underappreciated Programs to Shine in 2H23 and 2024
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
PACIFIC Enrollment Completes, Keeping 4Q23 Readout On Track
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
2Q23 Results; LP352 PACIFIC Readout on Track for 4Q23; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
All Cylinders Continuing to Fire Ahead of Upcoming PACIFIC Data Readout
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways From Recent Conferences: Nearing a Psychedelic Breakout With Plethora of Catalysts; LP352 to Shine in Epilepsy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
PACIFIC Data in Lead Epilepsy Program on Track for 4Q23
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P